ClinConnect ClinConnect Logo
Search / Trial NCT01832623

Vitamin D, Bones, Nutritional and Cardiovascular Status

Launched by HOSPICES CIVILS DE LYON · Apr 12, 2013

Trial Information

Current as of May 29, 2025

Completed

Keywords

Vitamin D Bone Cardiovascular Status Nutritional Status

ClinConnect Summary

To study the correlation between bone assessment by high-resolution peripheral quantitative computed tomography (HR-pQCT) and vitamin D serum concentration.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 10 year-old \<or= Age \< 18 year-old
  • Without mobility handicap (medical walker, crutch, wheelchair...)
  • Written informed consent (signed by parents)
  • Exclusion Criteria:
  • History of treatment with growth hormone
  • History of treatment with oral corticoids, taken over more than 3 consecutive months
  • Current treatment with growth hormone, corticoids or anti-calcineurin
  • Treatment with aspirin or nonsteroidal anti-inflammatory drug within the last three weeks
  • Treatment with paracetamol within the last week
  • * Chronic pathology with an impact on growth:
  • Parenteral nutrition
  • Chronic inflammatory disease (rheumatologic or digestive notably)
  • System diseases (lupus, granulomatosis, vascularitis)
  • Renal failure
  • Diabetes
  • Serious intercurrent disease (infection, neoplasia)
  • Ongoing pregnancy
  • Patient unaffiliated with the French universal healthcare system.

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Lyon, , France

Patients applied

0 patients applied

Trial Officials

Justine Bachetta, MD

Principal Investigator

Centre de Référence des Maladies Rénales Rares - Hospices Civils de Lyon - Service de Néphrologie et Rhumatologie Pédiatriques - Hôpital Femme Mère Enfant - 69500 BRON - FRANCE

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials